These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16013641)

  • 1. Report on the Belgian consensus meeting on colorectal cancer screening.
    Adler M; De Vos M; Dufour A; Janssens J; Laurent S; Melange M; Polus M; Op de Beeck B; Schapira M; Van Cutsem E; Van Gossum A
    Acta Gastroenterol Belg; 2005; 68(2):239-40. PubMed ID: 16013641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Individual screening for colorectal cancer: which strategy for which patient?].
    Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
    Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening in primary care: the long and short of it.
    Achkar E
    Am J Gastroenterol; 2004 May; 99(5):837-8. PubMed ID: 15128346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current trends in screening and secondary prevention of colorectal cancer.
    Crespi M; Stigliano V; Assisi D
    Hepatogastroenterology; 2001; 48(42):1635-40. PubMed ID: 11813590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flexible sigmoidoscopy as a screening test for colorectal cancer.
    Janssens JF
    Acta Gastroenterol Belg; 2005; 68(2):248-9. PubMed ID: 16013644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
    Baig N; Myers RE; Turner BJ; Grana J; Rothermel T; Schlackman N; Weinberg DS
    Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in screening for colorectal cancer--United States, 1997 and 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Mar; 50(9):162-6. PubMed ID: 11393486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal cancer.
    Saliangas K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality.
    Gellad ZF; Stechuchak KM; Fisher DA; Olsen MK; McDuffie JR; Ostbye T; Yancy WS
    Am J Gastroenterol; 2011 Jun; 106(6):1125-34. PubMed ID: 21304501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for colorectal cancer: the cost to find an advanced adenoma.
    McGrath JS; Ponich TP; Gregor JC
    Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for colorectal cancer--United States, 1992-1993, and new guidelines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Feb; 45(5):107-10. PubMed ID: 8592492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
    Solomon MJ; McLeod RS
    CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of colorectal cancer screening methods in Iran.
    Allameh Z; Davari M; Emami MH
    Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring complete diagnostic evaluation in colorectal cancer screening.
    Myers RE; Fishbein G; Hyslop T; Hauck WW; Kutch M; Grana JR; Schlackman N
    Cancer Detect Prev; 2001; 25(2):174-82. PubMed ID: 11341353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening.
    Bretthauer M
    J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.